Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.
By S. Harman, E. Jeffrey Metter, J. Tobin, J. Pearson, M. Blackman. Journal of Clinical Endocrinology and Metabolism, 2001
2,639 citations recorded by the source corpus.
Subfields: Behavioral Neuroscience, Cell Biology, Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/a345d65cf6d3945e64f95d65d9d754dc58e2ae99
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Behavioral Neuroscience
Citations in the corpus
- Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. (2002, positive): “124 nmol/liter/yr) in a third report (4).”
- Mate competition, testosterone and intersexual relationships in bonobos, Pan paniscus (2012, background): “Low levels of testosterone can also be associated with progressing senescence (Harman et al. 2001) and overall testosterone levels and reactivity to competition may be triggered by differences in social and physical development (Martin et al.”
- Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. (2006, background): “several cross-sectional and longitudinal studies (3, 4), results”
- Androgens and coronary artery disease. (2003, background): “Harman, 2001 (19) 890 Prospective cohort 31 yr T, free T index CAD Null”
- Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. (2010, positive): “Although testosterone therapy has been shown to increase lean body mass, muscle strength, vertebral bone mineral density, and some domains of sexual function, the benefits of therapy on patient-important outcomes–disability, vitality, fractures, and quality of life–remain largely unknown (1, 18).”
- Low serum testosterone and mortality in older men. (2008, background): “to have low testosterone (2), which is often accompanied by”
- Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. (2004, result): “We compared the prevalence of hypogonadism in our study (using the same criteria as BLSA) across various age ranges with the prevalence from BLSA.”
- Hormones and personality: Testosterone as a marker of individual differences (2007, background): “…individual diVerences in T. Future research needs to corroborate the impressive degree of short term stability documented in these studies by investigations into T's long-term stability over periods of months and years (but see Burger et al., 2000; Harman et al., 2001 for the eVects of aging on T).”
- The decline of androgen levels in elderly men and its clinical and therapeutic implications. (2005, background): “Aging is associated with important changes in body composition (108, 304, 305).”
- Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. (2010, background): “The average decline in serum testosterone levels with aging in men is 1–2% per year (7, 8).”